ES537459A0 - Procedimiento para preparar anticuerpos anti-idiotipicos - Google Patents

Procedimiento para preparar anticuerpos anti-idiotipicos

Info

Publication number
ES537459A0
ES537459A0 ES537459A ES537459A ES537459A0 ES 537459 A0 ES537459 A0 ES 537459A0 ES 537459 A ES537459 A ES 537459A ES 537459 A ES537459 A ES 537459A ES 537459 A0 ES537459 A0 ES 537459A0
Authority
ES
Spain
Prior art keywords
procedure
preparing anti
antibodies
idiotipic
idiotipic antibodies
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES537459A
Other languages
English (en)
Other versions
ES8900226A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
The Wistar Institute
Original Assignee
The Wistar Institute
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27069155&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ES537459(A0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from US06/549,506 external-priority patent/US4731237A/en
Application filed by The Wistar Institute filed Critical The Wistar Institute
Publication of ES537459A0 publication Critical patent/ES537459A0/es
Publication of ES8900226A1 publication Critical patent/ES8900226A1/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/42—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against immunoglobulins
    • C07K16/4208—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an idiotypic determinant on Ig
    • C07K16/4216—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an idiotypic determinant on Ig against anti-viral Ig
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/42—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against immunoglobulins
    • C07K16/4208—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an idiotypic determinant on Ig
    • C07K16/4241—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an idiotypic determinant on Ig against anti-human or anti-animal Ig
    • C07K16/4258—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an idiotypic determinant on Ig against anti-human or anti-animal Ig against anti-receptor Ig
    • C07K16/4266—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an idiotypic determinant on Ig against anti-human or anti-animal Ig against anti-receptor Ig against anti-tumor receptor Ig
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Virology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Genetics & Genomics (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Steroid Compounds (AREA)
ES537459A 1983-11-07 1984-11-07 Procedimiento para preparar anticuerpos anti-idiotipicos Expired ES8900226A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US54950583A 1983-11-07 1983-11-07
US06/549,506 US4731237A (en) 1983-11-07 1983-11-07 Immune response to virus induced by anti-idiotype antibodies

Publications (2)

Publication Number Publication Date
ES537459A0 true ES537459A0 (es) 1989-04-16
ES8900226A1 ES8900226A1 (es) 1989-04-16

Family

ID=27069155

Family Applications (1)

Application Number Title Priority Date Filing Date
ES537459A Expired ES8900226A1 (es) 1983-11-07 1984-11-07 Procedimiento para preparar anticuerpos anti-idiotipicos

Country Status (15)

Country Link
EP (2) EP0291636A1 (es)
JP (1) JP2633807B2 (es)
KR (1) KR910001127B1 (es)
AT (1) ATE45285T1 (es)
AU (1) AU596070B2 (es)
DE (1) DE3479289D1 (es)
DK (2) DK162056C (es)
ES (1) ES8900226A1 (es)
FI (1) FI87734C (es)
HU (1) HU194497B (es)
IL (1) IL73428A (es)
MY (1) MY100952A (es)
NZ (1) NZ210106A (es)
PT (1) PT79455A (es)
WO (1) WO1985002121A1 (es)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS59116230A (ja) * 1982-11-29 1984-07-05 ベイロ−・カレツジ・オヴ・メデイスン ウイルス性感染因子に対する免疫応答を生起する抗−イデイオタイプ抗体
WO1984004327A1 (en) * 1983-04-27 1984-11-08 Harvard College Method and products for detection of human t cell leukemia virus
WO1986000991A1 (en) * 1984-07-24 1986-02-13 Commonwealth Serum Laboratories Commission Method for determining mimotopes
NZ215865A (en) * 1985-04-22 1988-10-28 Commw Serum Lab Commission Method of determining the active site of a receptor-binding analogue
WO1986006487A1 (en) * 1985-04-22 1986-11-06 Commonwealth Serum Laboratories Commission Method for determining mimotopes
SE8601645D0 (sv) * 1986-04-11 1986-04-11 Ulf R Nilsson Immunologiskt forfarande
AU1484688A (en) * 1987-02-20 1988-09-14 Imclone Systems, Inc. Monoclonal antibodies in vaccine formulations
WO1988007058A1 (en) * 1987-03-16 1988-09-22 Biosolutions Pty. Ltd. Anti-paratopic antibody as an immunogen
AU662539B2 (en) * 1987-03-16 1995-09-07 Roland Keith Mcgready Anti-paratopic antibody as an immunogen
AU1436188A (en) * 1987-04-08 1988-10-13 Synbiotics Corp. Method for the early selection of anti-idiotype antibody internal images
US5217869A (en) * 1987-10-13 1993-06-08 Terrapin Technologies, Inc. Method to produce immunodiagnostic reagents
AU635492B2 (en) * 1987-10-13 1993-03-25 Telik, Inc. Method to produce immunodiagnostic reagents
US5227159A (en) * 1989-01-31 1993-07-13 Miller Richard A Anti-idiotype antibodies reactive with shared idiotopes expressed by B cell lymphomas and autoantibodies
US5493009A (en) * 1989-11-14 1996-02-20 New York Medical College Antiidiotypic monoclonal antibodies MK2-23 anti-melanomal antibody 763.74
DE69030172T2 (de) * 1990-01-26 1997-06-19 Immunomedics Inc Impfstoffe gegen Krebs und Infektionskrankheiten
US5969109A (en) * 1990-02-28 1999-10-19 Bona; Constantin Chimeric antibodies comprising antigen binding sites and B and T cell epitopes
WO1993015405A1 (en) * 1992-01-29 1993-08-05 Sci-Clone, Inc. Carcinoma associated antigen (sk1) monoclonal antibodies against sk1, methods of producing these antibodies and use therfor
US6008327A (en) 1992-03-13 1999-12-28 Akzo Nobel, N.V. Peptides and nucleic acid sequences related to the Epstein Barr virus
DE69332197T2 (de) * 1992-03-13 2003-04-17 Organon Teknika B.V., Boxtel Epstein-Barr-Virus verwandte Peptide und Nukleinsäuresegmenten
AU673347B2 (en) * 1992-03-17 1996-11-07 Novartis Ag Genetically engineered antibodies
CA2145278C (en) * 1992-09-25 2009-03-10 Commonwealth Scientific And Industrial Research Organisation Target binding polypeptide
EP0796280B1 (en) 1994-12-28 2003-03-26 University Of Kentucky Murine monoclonal anti-idiotype antibody 3h1
US6949244B1 (en) 1995-12-20 2005-09-27 The Board Of Trustees Of The University Of Kentucky Murine monoclonal anti-idiotype antibody 11D10 and methods of use thereof
ATE208403T1 (de) * 1995-05-26 2001-11-15 Merck Patent Gmbh Antiidiotypische antikörper die eine immunantwort gegen den rezeptor für epidermalen wachstumsfaktor induzieren
GB9908533D0 (en) 1999-04-14 1999-06-09 Novartis Ag Organic compounds

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4285955A (en) * 1978-10-31 1981-08-25 Bayer Aktiengesellschaft 1,4-Dihydropyridinecarboxylic acids
JPS59116230A (ja) * 1982-11-29 1984-07-05 ベイロ−・カレツジ・オヴ・メデイスン ウイルス性感染因子に対する免疫応答を生起する抗−イデイオタイプ抗体
US4692416A (en) * 1982-12-03 1987-09-08 Yeshiva University Monoclonal antibodies reactive with shared idiotypes on human antibodies to native DNA from patients with systemic lupus erythematosus

Also Published As

Publication number Publication date
EP0141783B2 (en) 1993-06-16
WO1985002121A1 (en) 1985-05-23
AU596070B2 (en) 1990-04-26
MY100952A (en) 1991-06-15
NZ210106A (en) 1990-05-28
HUT38841A (en) 1986-07-28
DK7891D0 (da) 1991-01-16
EP0141783A2 (en) 1985-05-15
JPH07194390A (ja) 1995-08-01
AU3614384A (en) 1985-06-03
FI852683A0 (fi) 1985-07-05
DK162605B (da) 1991-11-18
PT79455A (en) 1984-12-01
ATE45285T1 (de) 1989-08-15
KR850700111A (ko) 1985-10-25
JP2633807B2 (ja) 1997-07-23
HU194497B (en) 1988-02-29
DK310285A (da) 1985-07-05
DE3479289D1 (en) 1989-09-14
DK162056B (da) 1991-09-09
ES8900226A1 (es) 1989-04-16
IL73428A (en) 1991-04-15
DK162056C (da) 1992-02-17
KR910001127B1 (ko) 1991-02-25
EP0291636A1 (en) 1988-11-23
EP0141783A3 (en) 1985-07-03
EP0141783B1 (en) 1989-08-09
DK310285D0 (da) 1985-07-05
FI87734C (fi) 1993-02-25
FI852683L (fi) 1985-07-05
IL73428A0 (en) 1985-02-28
DK7891A (da) 1991-01-16
FI87734B (fi) 1992-11-13

Similar Documents

Publication Publication Date Title
FI852683L (fi) Immunisk motverkan foer tumoerer och virus.
FI834165A0 (fi) Stampkvarn med minst en lodraet eller snedstaelld, cylindrisk malkammare
NO162179C (no) Monoklonale antistoffer for anvendelse in vitro.
ES543085A0 (es) Procedimiento para preparar nuevos 2-fenil-imidazoles.
ES529728A0 (es) Procedimiento para preparar amino-2-fenil-5-benzodiazepinas-1, 3
MX161283A (es) Procedimiento para preparar((3,4-,4,5 y 5,6)piridilalquilensulfinil)benzimidazoles substituidos
FI842459A7 (fi) Tetrahydropyridatsinonijohdannaisia, menetelmiä niiden valmistamiseksi sekä niiden käyttö.
NO162797C (no) Monoklonalt antistofff for anvendelse in vitro.
FI841020A0 (fi) Sanitetsduk, engaongsbloeja eller motsvarande produkt med foerbaettrade sanitetsegenskaper
EP0131627A4 (en) SPECIFIC ANTIGENS OF THE CEA FAMILY (CARCINO-EMBRYONIC ANTIGEN), SPECIFIC ANTIBODIES OF THESE ANTIGENS AND THEIR METHODS OF USE.
AR240821A1 (es) Imidazopirrolpiridindiona, procedimiento e intermediarios para prepararlos
ES522008A0 (es) Procedimiento para preparar acepinoindoles.
FI870867A7 (fi) Menetelmä jatkuvasti lisääntyvien primäärisolujen valmistamiseksi.
ES522662A0 (es) Procedimiento para preparar piridil y quinolil-imidazolinonas.
ES505908A0 (es) Procedimiento para generar halogeno
BG36931A3 (en) Method for preparing substituted benzamide
BG35041A3 (bg) Метод за получаване на заместени 2-пиперидин-4-амино-6,7- диметоксихиназолини
ES529734A0 (es) Procedimiento para preparar 3-acil-2-nitrometilentetrahidro-2h-1, 3-tiazinas
ES531104A0 (es) Procedimiento para preparar fenoxianilinas y piridiloxianilinas sustituidas
FI834533A0 (fi) Behaollare, saerskilt blomkruka eller liknande
IT1170707B (it) Procedimento per preparare 2-ammino 5-nitro-benzofenone e suoi 2-alogeno-derivati
DE8301955U1 (de) Brennstoffbeheizte waermequelle
NO171643C (no) Antistoffer med dobbelte spesifisiteter, deres fremstilling og anvendelse
FI791962A7 (fi) Myrkyttömän rypsinsiemen- proteiinikonsentraatin valmistusmenetelmä.
FI843323L (fi) Kyvettenhet.

Legal Events

Date Code Title Description
FD2A Announcement of lapse in spain

Effective date: 20170627